Conclusion: The effect of combined medication is more effective, which is superior to SASP and probiotic group.
结论：培菲康胶囊与柳氮磺胺毗淀均可有效治疗浅，且联合用药效果更佳。
The medicine was taken by 113 patients in 7 hospitals, with a general efficacy of 88.06%, significantly different from that of group SASP (P<0.005).
该药经全国七家医院113例患者临床试用，总有效率达88.06%，与SASP组比较差异非常显著（P<0.005）。
The patients with rheumatoid arthritis with the slow NAT2 acetylator genotypes have been shown to have more side effects than fast acetylator genotypes when taking SASP.
同时也有研究发现慢型乙酰化表型的风湿性关节炎患者在服用SASP后，与快型乙酰化表型患者相比，副反应发生率明显升高。
Objective:To observe the efficacy and safety of Etiasa, a control released tablet of mesalazine, in treatment of inflammatory bowel disease(IBD) in comparison with salicylazosulfapyridine (SASP).
目的：观察一种新型美沙拉嗪控释剂（艾迪莎）治疗炎症性肠病（IBD）的疗效和安全性，并同水杨酸偶氮磺胺吡啶（SASP）进行比较。
Objective:To observe the efficacy and safety of Etiasa, a control released tablet of mesalazine, in treatment of inflammatory bowel disease(IBD) in comparison with salicylazosulfapyridine (SASP).
目的：观察一种新型美沙拉嗪控释剂（艾迪莎）治疗炎症性肠病（IBD）的疗效和安全性，并同水杨酸偶氮磺胺吡啶（SASP）进行比较。
应用推荐